Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 2023-02, Vol.78 (2), p.555-558
Main Authors: Graziani, Lucia, Gori, Leonardo, Manciulli, Tommaso, Basile, Gregorio, Campolmi, Irene, Borchi, Beatrice, di Dio, Marta, Mattei, Marta, Ciurleo, Greta, Ciliberti, Maria, Malentacchi, Francesca, Coppi, Marco, Morettini, Alessandro, Parronchi, Paola, Rossolini, Gian Maria, Bartoloni, Alessandro, Tomassetti, Sara, Spinicci, Michele
Format: Article
Language:English
Subjects:
COVID-19
COVID-19 Drug Treatment
Humans
Immunocompromised Host
Research Letter
Ritonavir - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c381t-f61d66d88a37a2a6fea003162f80315c1c69b67717a5dc1fae5c6ac1d218b03a3
cites cdi_FETCH-LOGICAL-c381t-f61d66d88a37a2a6fea003162f80315c1c69b67717a5dc1fae5c6ac1d218b03a3
container_end_page 558
container_issue 2
container_start_page 555
container_title Journal of antimicrobial chemotherapy
container_volume 78
creator Graziani, Lucia
Gori, Leonardo
Manciulli, Tommaso
Basile, Gregorio
Campolmi, Irene
Borchi, Beatrice
di Dio, Marta
Mattei, Marta
Ciurleo, Greta
Ciliberti, Maria
Malentacchi, Francesca
Coppi, Marco
Morettini, Alessandro
Parronchi, Paola
Rossolini, Gian Maria
Bartoloni, Alessandro
Tomassetti, Sara
Spinicci, Michele
description
doi_str_mv 10.1093/jac/dkac433
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9890247</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2757161108</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-f61d66d88a37a2a6fea003162f80315c1c69b67717a5dc1fae5c6ac1d218b03a3</originalsourceid><addsrcrecordid>eNpVkctL9TAQxYMoen2s3H9kKUi9maZJ240g1ycILnxsw9w01Wib1KRV_O-NeD_R1Qwzh9-c4RCyD-wIWM3nz6jnzQvqgvM1MoNCsixnNayTGeNMZGUh-BbZjvGZMSaFrDbJFpeiKLjIZ2S4nbQ2MbZTR6doqG-ps6HHMZjuzYZ5sKN3mDpqHbV9PzmvfT8E39toGjrgaI0bI3234xMdTIg2jmlA0TVzH2ii4BCte6SLm4er0wzqXbLRYhfN3qrukPvzs7vFZXZ9c3G1OLnONK9gzFoJjZRNVSEvMUfZGmSMg8zbKhWhQct6KcsSShSNhhaN0BI1NDlUS8aR75Djb-4wLXvT6GQqYKeGYHsMH8qjVX83zj6pR_-m6qpmeVEmwMEKEPzrZOKo0svadB0646eo8lKUIAFYlaSH31IdfIzBtD9ngKmvjFTKSK0ySup_v539aP-Hwj8B0CiRnA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2757161108</pqid></control><display><type>article</type><title>Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19</title><source>Oxford Journals Online</source><creator>Graziani, Lucia ; Gori, Leonardo ; Manciulli, Tommaso ; Basile, Gregorio ; Campolmi, Irene ; Borchi, Beatrice ; di Dio, Marta ; Mattei, Marta ; Ciurleo, Greta ; Ciliberti, Maria ; Malentacchi, Francesca ; Coppi, Marco ; Morettini, Alessandro ; Parronchi, Paola ; Rossolini, Gian Maria ; Bartoloni, Alessandro ; Tomassetti, Sara ; Spinicci, Michele</creator><creatorcontrib>Graziani, Lucia ; Gori, Leonardo ; Manciulli, Tommaso ; Basile, Gregorio ; Campolmi, Irene ; Borchi, Beatrice ; di Dio, Marta ; Mattei, Marta ; Ciurleo, Greta ; Ciliberti, Maria ; Malentacchi, Francesca ; Coppi, Marco ; Morettini, Alessandro ; Parronchi, Paola ; Rossolini, Gian Maria ; Bartoloni, Alessandro ; Tomassetti, Sara ; Spinicci, Michele</creatorcontrib><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/dkac433</identifier><identifier>PMID: 36544352</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>COVID-19 ; COVID-19 Drug Treatment ; Humans ; Immunocompromised Host ; Research Letter ; Ritonavir - therapeutic use</subject><ispartof>Journal of antimicrobial chemotherapy, 2023-02, Vol.78 (2), p.555-558</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c381t-f61d66d88a37a2a6fea003162f80315c1c69b67717a5dc1fae5c6ac1d218b03a3</citedby><cites>FETCH-LOGICAL-c381t-f61d66d88a37a2a6fea003162f80315c1c69b67717a5dc1fae5c6ac1d218b03a3</cites><orcidid>0000-0003-4829-9796</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36544352$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Graziani, Lucia</creatorcontrib><creatorcontrib>Gori, Leonardo</creatorcontrib><creatorcontrib>Manciulli, Tommaso</creatorcontrib><creatorcontrib>Basile, Gregorio</creatorcontrib><creatorcontrib>Campolmi, Irene</creatorcontrib><creatorcontrib>Borchi, Beatrice</creatorcontrib><creatorcontrib>di Dio, Marta</creatorcontrib><creatorcontrib>Mattei, Marta</creatorcontrib><creatorcontrib>Ciurleo, Greta</creatorcontrib><creatorcontrib>Ciliberti, Maria</creatorcontrib><creatorcontrib>Malentacchi, Francesca</creatorcontrib><creatorcontrib>Coppi, Marco</creatorcontrib><creatorcontrib>Morettini, Alessandro</creatorcontrib><creatorcontrib>Parronchi, Paola</creatorcontrib><creatorcontrib>Rossolini, Gian Maria</creatorcontrib><creatorcontrib>Bartoloni, Alessandro</creatorcontrib><creatorcontrib>Tomassetti, Sara</creatorcontrib><creatorcontrib>Spinicci, Michele</creatorcontrib><title>Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><subject>COVID-19</subject><subject>COVID-19 Drug Treatment</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Research Letter</subject><subject>Ritonavir - therapeutic use</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkctL9TAQxYMoen2s3H9kKUi9maZJ240g1ycILnxsw9w01Wib1KRV_O-NeD_R1Qwzh9-c4RCyD-wIWM3nz6jnzQvqgvM1MoNCsixnNayTGeNMZGUh-BbZjvGZMSaFrDbJFpeiKLjIZ2S4nbQ2MbZTR6doqG-ps6HHMZjuzYZ5sKN3mDpqHbV9PzmvfT8E39toGjrgaI0bI3234xMdTIg2jmlA0TVzH2ii4BCte6SLm4er0wzqXbLRYhfN3qrukPvzs7vFZXZ9c3G1OLnONK9gzFoJjZRNVSEvMUfZGmSMg8zbKhWhQct6KcsSShSNhhaN0BI1NDlUS8aR75Djb-4wLXvT6GQqYKeGYHsMH8qjVX83zj6pR_-m6qpmeVEmwMEKEPzrZOKo0svadB0646eo8lKUIAFYlaSH31IdfIzBtD9ngKmvjFTKSK0ySup_v539aP-Hwj8B0CiRnA</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Graziani, Lucia</creator><creator>Gori, Leonardo</creator><creator>Manciulli, Tommaso</creator><creator>Basile, Gregorio</creator><creator>Campolmi, Irene</creator><creator>Borchi, Beatrice</creator><creator>di Dio, Marta</creator><creator>Mattei, Marta</creator><creator>Ciurleo, Greta</creator><creator>Ciliberti, Maria</creator><creator>Malentacchi, Francesca</creator><creator>Coppi, Marco</creator><creator>Morettini, Alessandro</creator><creator>Parronchi, Paola</creator><creator>Rossolini, Gian Maria</creator><creator>Bartoloni, Alessandro</creator><creator>Tomassetti, Sara</creator><creator>Spinicci, Michele</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4829-9796</orcidid></search><sort><creationdate>20230201</creationdate><title>Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19</title><author>Graziani, Lucia ; Gori, Leonardo ; Manciulli, Tommaso ; Basile, Gregorio ; Campolmi, Irene ; Borchi, Beatrice ; di Dio, Marta ; Mattei, Marta ; Ciurleo, Greta ; Ciliberti, Maria ; Malentacchi, Francesca ; Coppi, Marco ; Morettini, Alessandro ; Parronchi, Paola ; Rossolini, Gian Maria ; Bartoloni, Alessandro ; Tomassetti, Sara ; Spinicci, Michele</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-f61d66d88a37a2a6fea003162f80315c1c69b67717a5dc1fae5c6ac1d218b03a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>COVID-19</topic><topic>COVID-19 Drug Treatment</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Research Letter</topic><topic>Ritonavir - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Graziani, Lucia</creatorcontrib><creatorcontrib>Gori, Leonardo</creatorcontrib><creatorcontrib>Manciulli, Tommaso</creatorcontrib><creatorcontrib>Basile, Gregorio</creatorcontrib><creatorcontrib>Campolmi, Irene</creatorcontrib><creatorcontrib>Borchi, Beatrice</creatorcontrib><creatorcontrib>di Dio, Marta</creatorcontrib><creatorcontrib>Mattei, Marta</creatorcontrib><creatorcontrib>Ciurleo, Greta</creatorcontrib><creatorcontrib>Ciliberti, Maria</creatorcontrib><creatorcontrib>Malentacchi, Francesca</creatorcontrib><creatorcontrib>Coppi, Marco</creatorcontrib><creatorcontrib>Morettini, Alessandro</creatorcontrib><creatorcontrib>Parronchi, Paola</creatorcontrib><creatorcontrib>Rossolini, Gian Maria</creatorcontrib><creatorcontrib>Bartoloni, Alessandro</creatorcontrib><creatorcontrib>Tomassetti, Sara</creatorcontrib><creatorcontrib>Spinicci, Michele</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Graziani, Lucia</au><au>Gori, Leonardo</au><au>Manciulli, Tommaso</au><au>Basile, Gregorio</au><au>Campolmi, Irene</au><au>Borchi, Beatrice</au><au>di Dio, Marta</au><au>Mattei, Marta</au><au>Ciurleo, Greta</au><au>Ciliberti, Maria</au><au>Malentacchi, Francesca</au><au>Coppi, Marco</au><au>Morettini, Alessandro</au><au>Parronchi, Paola</au><au>Rossolini, Gian Maria</au><au>Bartoloni, Alessandro</au><au>Tomassetti, Sara</au><au>Spinicci, Michele</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>78</volume><issue>2</issue><spage>555</spage><epage>558</epage><pages>555-558</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>36544352</pmid><doi>10.1093/jac/dkac433</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-4829-9796</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 2023-02, Vol.78 (2), p.555-558
issn 0305-7453
1460-2091
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9890247
source Oxford Journals Online
subjects COVID-19
COVID-19 Drug Treatment
Humans
Immunocompromised Host
Research Letter
Ritonavir - therapeutic use
title Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T22%3A11%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20use%20of%20nirmatrelvir/ritonavir%20in%20immunocompromised%20patients%20with%20persistent%20and/or%20relapsing%20COVID-19&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Graziani,%20Lucia&rft.date=2023-02-01&rft.volume=78&rft.issue=2&rft.spage=555&rft.epage=558&rft.pages=555-558&rft.issn=0305-7453&rft.eissn=1460-2091&rft_id=info:doi/10.1093/jac/dkac433&rft_dat=%3Cproquest_pubme%3E2757161108%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c381t-f61d66d88a37a2a6fea003162f80315c1c69b67717a5dc1fae5c6ac1d218b03a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2757161108&rft_id=info:pmid/36544352&rfr_iscdi=true